title: Familial amyloidotic polyneuropathy and transthyretin.
abstract: There has been much progress in our understanding of transthyretin (TTR)-related amyloidosis including familial amyloidotic polyneuropathy (FAP), senile systemic amyloidosis and its related disorders from many clinical and experimental aspects. FAP is an inherited severe systemic amyloidosis caused by mutated TTR, and characterized by amyloid deposition mainly in the peripheral nervous system and the heart. Liver transplantation is the only available treatment for the disease. FAP is now recognized not to be a rare disease, and to have many variations based on genetical and biochemical variations of TTR. This chapter covers the recent advances in the clinical and pathological aspects of, and therapeutic approaches to FAP, and the trend as to the molecular pathogenesis of TTR.
authors.affiliation: Department of Neurology, University of Yamanashi, 1110 Shimokato, 409-3898, Chuou-city, Yamanashi, Japan, nagat@yamanashi.ac.jp.
authors.forename: Takamura
authors.initials: T
authors.lastname: Nagasaka
mesh_terms: D000682:Amyloid / Q000235:genetics / Q000378:metabolism; D028227:Amyloid Neuropathies, Familial / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D000818:Animals; D006801:Humans; D016031:Liver Transplantation; D009154:Mutation; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D017933:Peripheral Nervous System / Q000378:metabolism / Q000473:pathology; D011228:Prealbumin / Q000235:genetics / Q000378:metabolism
chemical_list: D000682:Amyloid; D011228:Prealbumin